Add like
Add dislike
Add to saved papers

Unprecedented NH 2 -MIL-101(Al)/n-Bu 4 NBr system as solvent-free heterogeneous catalyst for efficient synthesis of cyclic carbonates via CO 2 cycloaddition.

Amine-functionalised framework NH2 -MIL-101(Al) was synthesized using a solvothermal and microwave method and characterized by PXRD, FT-IR, TGA, SEM-EDX, and BET surface area analysis. The desolvated framework, in the presence of co-catalyst tetrabutylammonium bromide (TBAB), acted as an excellent heterogeneous catalyst for the solvent-free cycloaddition of carbon dioxide (CO2 ) with epoxides, affording five-membered cyclic carbonates. Using styrene oxide, the NH2 -MIL-101(Al)/TBAB system showed more than 99% conversion, affording 96% yield and 99% selectivity with a turn over frequency of 23.5 h-1 . This validated the synergistic effect of the quaternary ammonium salt during CO2 cycloaddition. The catalyst could be recycled at least five times without a noticeable loss in activity, while leaching test showed no leached Al3+ ions throughout the reaction. Thorough analysis of the reaction parameters showed that the optimum conditions for obtaining the maximum yield and highest selectivity were 120 °C and 18 bar of CO2 for 6 h. The outstanding conversion and selectivity were maintained for a range of aliphatic and aromatic epoxides, corroborating the duel benefit of the micro-mesoporous system with amine functionality, which offered easy access for reactant molecules with diverse sizes, and provided inspiration for future CO2 cycloaddition catalytic systems. We also propose a rationalized mechanism for the cycloaddition reaction mediated by NH2 -MIL-101(Al) and TBAB based on literature precedent and experimental outcome.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app